Heart failure & cardiomyopathies

Diuretic strategies in acute heart failure: a systematic review and network meta-analysis of randomized clinical trials

Eur Heart J Cardiovasc PharmacotherPublished systematic review and network meta-analysis of randomized clinical trials

Authors' conclusion

FC and SNB improve surrogates of response to FB in AHF. SNB is also connoted by WRF and may induce hypokalaemia. The endpoints of diuretic RCTs should be revised and harmonized.

Study context

Population
Admitted acute heart failure (AHF) patients within 48 h, irrespective of clinical stabilizationpatients in 25 selected randomized clinical trials (RCTs), mean age 68.9 ± 8.7 years, mean left ventricular ejection fraction 38.2 ± 10.7%
Participants
7,149 patients
Comparison
FC or FB plus another diuretic compared to FB alone
Outcome
Weight loss (WL)
Follow-up
24 h
Methodological detailsphase 3 randomized clinical trials, random-effects model with inverse variance weighting
  • Phase 3 randomized clinical trials
  • Random-effects model with inverse variance weighting

Pooled result

As reported in the abstract

Greater WL
Each group vs FBOdds ratio (95% CI)
FC
1.55(1.39–1.63)
FB plus tolvaptan
1.57(1.39–1.77)
FB plus SGLT2i
1.23(1.06–1.42)
FB plus thiazide
1.63(1.37–1.94)

Further pooled results

OutcomeOR (CI)
Mortality/rehospitalizationFB plus SGLT2ivs FBNon-significantly lower with SGLT2i · underpowered exploratory analysis0.45 (0.19–1.07)

Sensitivity analyses (urine output, protocol-established furosemide doses, daily furosemide dose)

Results were consistent in sensitivity analyses

Reporting of congestion/decongestion scores and clinical outcomes

Reported in around 50% of RCTs
around 50%

Safety

OutcomeOR (CI)
Worsening renal function (WRF)FB plus SGLT2ivs FB1.52 (1.19–1.94)
Worsening renal function (WRF)FB plus acetazolamidevs FB1.81 (1.31–2.49)
Worsening renal function (WRF)FB plus thiazidevs FB1.78 (1.43–2.21)
HypokalaemiaFB plus thiazidevs FB1.69 (1.32–2.16)

Original publication

Diuretic strategies in acute heart failure: a systematic review and network meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Pharmacother. Published 10 September 2025. doi:10.1093/ehjcvp/pvaf067

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.